03-5806-9776 9:00~18:00(定休日:土・日・祝)




クリニカルオペレーションズ(CRC) BI20180508-04

掲載開始日 2018.05.08



<Basic Purpose of the job>
1. To steer the management of the clinical trials from Phase I to Phase IV in Japan according to the clinical development plans in order to obtain regulatory approval in Japan and contribute to international clinical development with the target to optimally address speed, quality, cost, EE involvement and efficiency of preparation, conduct, analysis and reporting of clinical trials (appendix preparation) within the definitions set by legal and regulatory boundaries and ethical standards.
• Act as the main interface between OPU and TCM
• Manage and ensure the assigned clinical trial performance on OPU level
• Take leadership of local trial team
• Ensure inspection readiness activities for the trial on OPU level

2. To contribute to the improvement of internal processes, structures and procedures within ClinOps Japan as well as overall BI Medicine and other functions.

<Accountabilities >
• Execute responsible trial within the agreed timelines
• Establish and ensure subject recruitment with recruitment risk identification and countermeasure setting
• Conduct appropriate site selection and ensure training completion for investigators and site staffs
• Prepare local trial documents and ensure ISF contents
• Lead the local trial team and report progress to relevant stakeholders incl. TCM, local management and cross-functional structure
• Lead data-cleaning activities
• Ensure compliances of CTMS
• Develop and maintain the relationship with investigators, consultants, vendors, contract research organizations

-Establish appropriate subject recruitment plan and identify possible risks and counter measures to achieve the target
- Achievement rate of No of recruited subjects in Japan compare with that in trial total and required rate for committed No in Japan
-Deliverables listed in the Communication Plan for Japan Trial Team
-Minutes for Japan Trial Team Meeting including CRA meeting
-Contribution of PMDA meeting
-Query response after CTN

• Execute responsible trial with the expected quality: MVR review, audit report review and action plan, non-compliance CAPA completion
• Oversight and manage required operational activities to ensure high quality of data compliance with SOPs, ICH-GCP/J-GCP and other applicable regulations
• Ensure timely document transfer to TMF
• Ensure inspection readiness activities for the trial on OPU level

-Minutes for Japan Trial Team Meeting including CRA meeting
-Number of Non Compliance reported, rate of major/critical NC, GEM update status
- Audit outcomes, Inspection results

• Prepare local trial budget precisely and get approval by TCM and local management
• Proceed negotiation with study site for milestone payment procedure and FMV principle
• Conduct trial with the agreed budget and update the budget continuously
• Escalate deviation to TCM and local management

-Trial budget deviations, actual per patient cost
-Rate of sites with milestone or visit based payment
-Trial budget deviations, actual per patient cost

• Ensure involvement of appropriate external expert sites in responsible trial with close relationship with cross functional team members
-The rate of EE sites in the trial

<Other regulatory and / or Organizational Requirements>
GCP, local clinical trial regulations and guidelines• Global CML training

<Business / functions specific measures, e.g.. sales:>
Job complexity factors
• Identification of potential risks on OPU level and propose solution
• Identification of recruitment difficulty on OPU level and solution proposal
•Communication and relationship with Coordinating Investigator and stakeholders
• Cross-functional communication and connection

勤務地 東京
年収 経験等を考慮の上、同社規定により決定されます。
応募資格・スキル <Required Education>
• Bachelor degree in medicine related sciences (including pharmacy, nursing, biology, public health and soon)

<Required Skills>
Special Skills
• Project management
• Interpersonal communication for leadership
• Global communication
• Medical writing
• Presentation
備考 同社は研究開発主導型の製薬メーカーで、世界トップ20の内の一社です。 ドイツに本社拠点を置き、全世界100か国以上、47,700人以上の社員が事業を展開しています。2014年には13.3億ユーロの売り上げを達成し、その売り上げの23.1%を研究開発費に投資しています。





Future Opportunity Resource

TEL 03-5806-9776
FAX 03-3843-8188



F.O.R の事業